Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP639857.RAawgKnWzVRvu0KMNYxXyT-pYrpUHP7Oj3I_LB_ZedUF4130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP639857.RAawgKnWzVRvu0KMNYxXyT-pYrpUHP7Oj3I_LB_ZedUF4130_provenance.
• NP815757.RAYo1smkrvFPpjED8xaKjJ53c_LdkT98SfAmAqvFBKgO4130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815757.RAYo1smkrvFPpjED8xaKjJ53c_LdkT98SfAmAqvFBKgO4130_provenance.
• NP200015.RAG0MFcgXI1BufJF8ToIQJd6XkIHm27-0-cAE6E1_FTOI130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP200015.RAG0MFcgXI1BufJF8ToIQJd6XkIHm27-0-cAE6E1_FTOI130_provenance.
• NP224856.RAoaSfHElCiu46LoJ-HgPvhWPKyC2_VhoSkEMJch_rPXI130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP224856.RAoaSfHElCiu46LoJ-HgPvhWPKyC2_VhoSkEMJch_rPXI130_provenance.
• NP528597.RAlMFY-xo3-37f3X6tb-D86u4-CeIrFekZw9z7J9WIQgE130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528597.RAlMFY-xo3-37f3X6tb-D86u4-CeIrFekZw9z7J9WIQgE130_provenance.
• NP570863.RAvUFTlEMjM-3qptAndyF10MMXZPdmfeLkjyyjYI3ZiWo130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570863.RAvUFTlEMjM-3qptAndyF10MMXZPdmfeLkjyyjYI3ZiWo130_provenance.
• NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_provenance.
• assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP416952.RANby7rVOazXRmcoWisSQMEXzy5GLaSI2g36cJl6BQ4vE130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416952.RANby7rVOazXRmcoWisSQMEXzy5GLaSI2g36cJl6BQ4vE130_provenance.
• NP428530.RAxQJkSxJRSGYUp7GRpUymMw3-orWPGW_EQRIjkKUL8mY130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428530.RAxQJkSxJRSGYUp7GRpUymMw3-orWPGW_EQRIjkKUL8mY130_provenance.
• NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_provenance.
• NP312171.RAWOXHuaXsXYG-Sh193eLexEprVmGnps2vvU7kthlQSxM130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312171.RAWOXHuaXsXYG-Sh193eLexEprVmGnps2vvU7kthlQSxM130_provenance.
• NP312225.RAbNGO8MbCxf9G13zjr8eRruAbOYsZt-JtHg9VU1HUly4130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312225.RAbNGO8MbCxf9G13zjr8eRruAbOYsZt-JtHg9VU1HUly4130_provenance.
• NP658028.RA_yyb2nIRWSk-aUDgj2pP1Ih4KMPTqKyM-a8eCtxoQm0130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658028.RA_yyb2nIRWSk-aUDgj2pP1Ih4KMPTqKyM-a8eCtxoQm0130_provenance.
• NP687146.RAybHDKgcQoyoH6VjpXP-si2sm61trfSo68cMMVl-SU7I130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687146.RAybHDKgcQoyoH6VjpXP-si2sm61trfSo68cMMVl-SU7I130_provenance.
• NP830794.RA2VduW13BfOtavKsdUJf4urXViiRc3ZC7rcZDsWVFipQ130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830794.RA2VduW13BfOtavKsdUJf4urXViiRc3ZC7rcZDsWVFipQ130_provenance.
• assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP651188.RAiSBmuw04EmB8HYKgxo5seMk5Guu1B2rFLG05uCdc9Sg130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651188.RAiSBmuw04EmB8HYKgxo5seMk5Guu1B2rFLG05uCdc9Sg130_provenance.
• NP308983.RABquME3tbVIpRFKvy6GRk7NACIDO_cbdmqqfBXAD1pQ4130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308983.RABquME3tbVIpRFKvy6GRk7NACIDO_cbdmqqfBXAD1pQ4130_provenance.
• NP879050.RAdvzANrejQ6RwgkY86kXHjUH4no0NIRm4AMxpKOzZRbE130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879050.RAdvzANrejQ6RwgkY86kXHjUH4no0NIRm4AMxpKOzZRbE130_provenance.
• NP879045.RAl2TL5XYjjxgaAKKSsmotWT054qJ34egbUXK5pDcf7Bs130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879045.RAl2TL5XYjjxgaAKKSsmotWT054qJ34egbUXK5pDcf7Bs130_provenance.
• NP879052.RAmipi3XEBTaMSyxoND5nS4akvhxHdPBSehatOOx743j0130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879052.RAmipi3XEBTaMSyxoND5nS4akvhxHdPBSehatOOx743j0130_provenance.
• NP879056.RAtnYGyX1LLA8C2lwwPBJVTaV1Qsfw_6TyGwhWMLCn8GE130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879056.RAtnYGyX1LLA8C2lwwPBJVTaV1Qsfw_6TyGwhWMLCn8GE130_provenance.
• NP311941.RA094u0325vlWqlKHzT5qBtg1ezmCW_2RiHxZ3vkTjPwA130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311941.RA094u0325vlWqlKHzT5qBtg1ezmCW_2RiHxZ3vkTjPwA130_provenance.
• NP309062.RA-JYlP4_tsfQNlaNXWiT7mAAXkXeJVARtrhx7ls_tJuo130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309062.RA-JYlP4_tsfQNlaNXWiT7mAAXkXeJVARtrhx7ls_tJuo130_provenance.
• NP651136.RAzXwyR17B4Sa-zjdxWp1mslD_opz3ayWgPDxhwwk7adY130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651136.RAzXwyR17B4Sa-zjdxWp1mslD_opz3ayWgPDxhwwk7adY130_provenance.
• NP879048.RAOoZGqs2oelWpZ2LkVTHXxHNazbNvWLF1gEtRHCVkhss130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879048.RAOoZGqs2oelWpZ2LkVTHXxHNazbNvWLF1gEtRHCVkhss130_provenance.
• NP879055.RAEDHF5VNA_iAjEgMG4WY992EOMVZR80lgV2foo37UiM8130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879055.RAEDHF5VNA_iAjEgMG4WY992EOMVZR80lgV2foo37UiM8130_provenance.
• NP879053.RA5AkFLzD0Z3JrjLPjlGdinnHqMW17PlIn27pvE42TTuc130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879053.RA5AkFLzD0Z3JrjLPjlGdinnHqMW17PlIn27pvE42TTuc130_provenance.
• NP879054.RAxREaiVNXHJ81EteJw0rlwTmQy0BXvuVbxRYkfbf_45o130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879054.RAxREaiVNXHJ81EteJw0rlwTmQy0BXvuVbxRYkfbf_45o130_provenance.